Racial/Ethnic Differences and Trends in Pathologic Complete Response Following Neoadjuvant Chemotherapy for Breast Cancer.

Authors

Sung Jun Ma
Lucas M Serra
Brian Yu
Mark K Farrugia
Austin J Iovoli
Han Yu
Song Yao
Oluwadamilola T Oladeru
Anurag K Singh

Publication/Presentation Date

1-21-2022

Abstract

The purpose of this study was to evaluate nationwide trends in pathologic complete response (pCR) and its racial variations for breast cancer. The National Cancer Database was queried for women from 2010 to 2017 with non-metastatic breast cancer who underwent neoadjuvant chemotherapy. The primary endpoints, pCR and overall survival, were evaluated using Cochran-Armitage test, logistic, and Cox regression multivariable analyses. A total of 104,161 women were analyzed. Overall, pCR improved from 2010 to 2017 (15.1% to 27.2%, trend

Volume

14

Issue

3

ISSN

2072-6694

Published In/Presented At

Ma, S. J., Serra, L. M., Yu, B., Farrugia, M. K., Iovoli, A. J., Yu, H., Yao, S., Oladeru, O. T., & Singh, A. K. (2022). Racial/Ethnic Differences and Trends in Pathologic Complete Response Following Neoadjuvant Chemotherapy for Breast Cancer. Cancers, 14(3), 534. https://doi.org/10.3390/cancers14030534

Disciplines

Medicine and Health Sciences

PubMedID

35158802

Department(s)

Fellows and Residents

Document Type

Article